Clinical Trial Update: Cabozantinib for Patients With Recurrent or Progressive Meningioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating cabozantinib in patients with recurrent or progressive meningioma and is currently recruiting at Baptist Health South Flo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• Cabozantinib (Cabometyx) (cabozantinib)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Meningioma | Phase 2 | Status: RECRUITING